GSA Capital Partners »

Verve Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Verve Therapeutics (VERV) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Verve Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Verve Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verve Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2025-06-30 $437k 39k 11.23
2025-03-31 $996k 218k 4.57
2024-12-31 $785k 139k 5.64
2024-09-30 $175k 36k 4.85
2024-06-30 $994k 204k 4.88
2023-09-30 $754k 57k 13.25
2023-03-31 $783k 54k 14.42
2022-06-30 $390k 26k 15.27